SPONTAN to be Evaluated in Pulmonary Arterial Hypertension Following Ethics Approval 22 October 2026 Highlights ® • Ethics approval received for an investigator-initiated clinical study evaluating SPONTAN in pulmonary ar- terial hypertension (PAH), a serious, progressive and currently incurable...